Shaanxi Micot shares nearly double in Hong Kong trading debut
Shares of drugmaker Shaanxi Micot Pharmaceutical Technology Co. Ltd. (2335.HK) jumped in their Hong Kong trading debut on Wednesday, after the company raised HK$989 million ($126 million) by selling about…
BRIEF: Everest Medicines advances with major licensing deal, new drug application approval
Everest Medicines Ltd. (1952.HK) last Thursday announced an exclusive licensing agreement to commercialize Micot’s MT1013 for the treatment of secondary hyperparathyroidism (SHPT), worth up to 1.24 billion yuan ($179 million).…
RELATED ARTICLES
-
BRIEF: LDRobot shares double in Hong Kong trading debut
1236.HK -
BRIEF: Everest Medicines advances with major licensing deal, new drug application approval
1952.HK
-
BRIEF: Shanghai FourSemi shares double in Hong Kong debut
3625.HK
-
BRIEF: Sunmi Technology shares leap in Hong Kong trading debut
6810.HK
-
Kintor regeneration advances with new marketing partnership
9939.HK
- Mega licensing deal lifts 3SBio profits but core sales slip
-
BRIEF: GPU maker Biren Technology soars in Hong Kong trading debut
6082.HK
